The story of dying in the 21st century is a story of paradox. While many people are overtreated
in hospitals with families and communities relegated to the margins, still more remain …

Purpose Eicosapentaenoic acid (EPA) has been proposed to have specific anticachectic
effects. This trial compared EPA diethyl ester with placebo in cachectic cancer patients for …

In spite of recent advances in anti-cancer treatments, most adult cancer patients still ultimately
die from their disease. There should therefore be free access to palliative care around the …

Supportive care plays an increasingly important role in the modern management of multiple
myeloma. While modern treatments have significantly prolonged overall and progression …

Advance statements about medical care have been heralded by some as a solution to the
problem of end of life decision making for people not able to participate in discussions about …

… Professor SH Ahmedzai has received research funding, honoraria, provided consultancies
and participated in advisory boards for Archimedes, Cephalon, Grünenthal, … Sam H Ahmedzai …

Aim To evaluate the long-term safety and efficacy of prolonged-release oxycodone/naloxone
(OXN PR) and its impact on quality of life (QoL), in patients with moderate-to-severe cancer …

Context The cumulative impact of disease and treatment-related factors on health-related
quality of life (HRQoL) in long-term survivors of multiple myeloma is poorly characterized. …

Background and objective Pain is a common symptom in patients who survive cancer and in
those who live with progressive advanced disease. Evidence from meta‐analyses suggests …

Background According to EU policy, anyone in need of palliative care should be able to have
access to it. It is therefore important to investigate which palliative care topics are subject to …